Calithera's $480M+ tie-up with Incyte re arginase bid beats hard on combo drum
After one analyst earlier this month referred to Calithera Biosciences Inc.'s benefit from "pairing promiscuously" with the lead candidate in its pipeline, the company matched efforts in a different way with Incyte Corp. on an early stage prospect, and stands to collect not only $45 million up front and an $8 million equity investment but also as much as $430 million in milestone payments.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST